DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Online

Drug Development Phase 4 and Lifecycle Management

Review activities associated with the management of a marketed drug, as well as focus on how companies maximize the value of approved products through the lifecycle management process.

Continuing Education

ACPEThe Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation. The Drug Information Association designates this educational activity for up to .75 contact hours or .075 continuing education units (CEUs). Type of Activity: Application 0286-0000-24-067-H04-P

PMIDIA has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI).
This program offers a maximum of .75 professional development unit (PDUs).
PMI #: 216629SJF9

The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.

IACETDrug Information Association (DIA) is accredited by the International Accreditors for Continuing Education and Training (IACET) and offers IACET CEUs for its learning events that comply with the ANSI/IACET Continuing Education and Training Standard. IACET is recognized internationally as a standard development organization and accrediting body that promotes quality of continuing education and training.

As an IACET Accredited Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer .1 CEUs for this program.

Release Date: July 18, 2018

Reviewed and Updated: July 14, 2021

Expiration Date: July 14, 2024*

*Continuing education credit is available to participants who successfully complete the eLearning program before the expiration date.
NameCredit TypeMax CreditsCEU
Drug Development Phase 4 and Lifecycle Management Credit TypeACPEMax Credits0.75CEU0.075
Drug Development Phase 4 and Lifecycle Management Credit TypeIACETMax Credits0.75CEU0.100
Drug Development Phase 4 and Lifecycle Management Credit TypePMIMax Credits0.75CEU0.000

Statement of Credit:

Statement of Credit and Successful Completion Requirements
To successfully complete this course and receive a statement of credit, you must review at least 90% of the module, achieve a passing score of 80% or better on the post-assessment, and complete the evaluation.

After a module is completed, you will be able to access the module for one year from the date of purchase.

Sign in to My Account to access My Transcripts and request your online credit.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。